News Release - September 18, 2007

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

Source: Tibotec Therapeutics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.